Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free ELTX Stock Alerts

Elicio Therapeutics (ELTX) Institutional Ownership

Elicio Therapeutics logo
$10.59 -0.18 (-1.67%)
Closing price 04:00 PM Eastern
Extended Trading
$10.72 +0.13 (+1.22%)
As of 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Elicio Therapeutics (NASDAQ:ELTX)

Current
Institutional Ownership
Percentage
35.03%
Number of
Institutional Buyers
(last 12 months)
22
Total
Institutional Inflows
(last 12 months)
$5.00M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$507.58K
Get ELTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Elicio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ELTX Institutional Buying and Selling by Quarter

Elicio Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/27/2026 HB Wealth Management LLC10,463$112K0.0%N/A0.057%
2/18/2026Quadrature Capital Ltd17,159$137K0.0%N/A0.098%
2/18/2026Occudo Quantitative Strategies LP15,827$126K0.0%N/A0.090%
2/18/2026Balyasny Asset Management L.P.138,762$1.11M0.0%-6.3%0.793%
2/18/2026683 Capital Management LLC56,442$449K0.0%N/A0.323%
2/16/2026Squarepoint Ops LLC16,662$133K0.0%N/A0.095%
2/16/2026OMERS ADMINISTRATION Corp23,500$187K0.0%N/A0.134%
2/13/2026Marshall Wace LLP117,200$933K0.0%+35.4%0.670%
2/13/2026State Street Corp46,300$369K0.0%+20.9%0.265%
2/13/2026Summit Financial LLC10,010$80K0.0%N/A0.057%
2/12/2026Renaissance Technologies LLC28,111$224K0.0%-42.2%0.161%
2/9/2026Geode Capital Management LLC132,518$1.06M0.0%+2.2%0.758%
2/9/2026Jefferies Financial Group Inc.11,942$95K0.0%-40.9%0.068%
2/6/2026HighTower Advisors LLC11,186$89K0.0%N/A0.064%
2/2/2026CM Management LLC25,000$199K0.2%+316.7%0.143%
11/21/2025CIBC Bancorp USA Inc.32,000$350K0.0%N/A0.183%
11/17/2025Susquehanna International Group LLP120,207$1.32M0.0%+606.1%0.687%
11/17/2025Millennium Management LLC22,846$250K0.0%N/A0.131%
11/17/2025Bank of America Corp DE3,585$39K0.0%+186.8%0.020%
11/13/2025CM Management LLC6,000$66K0.1%-76.0%0.037%
11/12/2025Cresset Asset Management LLC26,925$295K0.0%N/A0.165%
11/7/2025Vanguard Group Inc.473,859$5.18M0.0%+4.2%2.900%
8/14/2025Raymond James Financial Inc.6,000$46K0.0%N/A0.037%
8/8/2025Geode Capital Management LLC120,831$933K0.0%+56.0%0.755%
8/4/2025 Mayflower Financial Advisors LLC10,000$77K0.0%N/A0.063%
5/19/2025Jane Street Group LLC14,993$92K0.0%N/A0.139%
5/15/2025Royal Bank of Canada36,537$225K0.0%N/A0.339%
5/9/2025CM Management LLC55,000$339K0.3%+37.5%0.510%
4/28/2025Moody Lynn & Lieberson LLC10,000$62K0.0%N/A0.093%
2/7/2025CM Management LLC40,000$204K0.2%-20.0%0.371%
8/15/2024Armistice Capital LLC100,000$411K0.0%N/A0.978%
8/9/2024Warberg Asset Management LLC11,801$49K0.0%N/A0.115%
8/2/2024CM Management LLC50,000$206K0.2%-33.3%0.489%
5/14/2024CM Management LLC75,000$570K0.5%+50.0%0.733%
8/4/2023CM Management LLC65,000$618K0.6%N/A2.159%


ELTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELTX shares?

During the previous two years, 28 institutional investors and hedge funds held shares of Elicio Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($5.18M), Susquehanna International Group LLP ($1.32M), Balyasny Asset Management L.P. ($1.11M), Geode Capital Management LLC ($1.06M), Marshall Wace LLP ($933K), 683 Capital Management LLC ($449K), and Armistice Capital LLC ($411K).Learn more on Elicio Therapeutics' institutional investors.

What percentage of Elicio Therapeutics' stock is owned by institutional investors?

35.03% of Elicio Therapeutics' stock is owned by institutional investors. Learn more on ELTX's institutional investor holdings.

Which institutional investors have been buying Elicio Therapeutics' stock?

Of the 25 institutional investors that purchased Elicio Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Susquehanna International Group LLP ($103.18K), Armistice Capital LLC ($100K), CM Management LLC ($59K), 683 Capital Management LLC ($56.44K), Geode Capital Management LLC ($46.20K), Royal Bank of Canada ($36.54K), and CIBC Bancorp USA Inc. ($32K).

How much institutional buying is happening at Elicio Therapeutics?

Institutional investors have bought a total of 554,172 shares in the last 24 months. This purchase volume represents approximately $5.00M in transactions.

Which of Elicio Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Elicio Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($20.56K), CM Management LLC ($19K), Balyasny Asset Management L.P. ($9.31K), and Jefferies Financial Group Inc. ($8.26K).

How much institutional selling is happening at Elicio Therapeutics?

Institutional investors have sold a total of 57,132 shares in the last 24 months. This volume of shares sold represents approximately $507.58K in transactions.


Related Companies

This page (NASDAQ:ELTX) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel